Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume 7, Issue -, Pages 102-109
Publisher
Wiley
Online
2016-04-19
DOI
10.1111/jdi.12490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study
- (2016) Jung Hun Ohn et al. Lancet Diabetes & Endocrinology
- β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
- (2015) Daisuke Yabe et al. Current Diabetes Reports
- Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
- (2015) S. E. Inzucchi et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials
- (2015) A. S. Abbas et al. DIABETES OBESITY & METABOLISM
- Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial
- (2015) Hitoshi Kuwata et al. DIABETOLOGIA
- Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients
- (2015) Daisuke Yabe et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan
- (2015) Yun-Ju Lai et al. MEDICINE
- Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study
- (2015) Shinichi Umezawa et al. BMC Endocrine Disorders
- Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs
- (2014) D. Yabe et al. DIABETES OBESITY & METABOLISM
- Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis
- (2014) Y. G. Kim et al. DIABETES OBESITY & METABOLISM
- Ethnic Differences in Insulin Sensitivity, β-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis
- (2014) Jonas B. Møller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Gastric emptying and glycaemia in health and diabetes mellitus
- (2014) Liza K. Phillips et al. Nature Reviews Endocrinology
- Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
- (2014) Tse-Ying Chen et al. POSTGRADUATE MEDICINE
- Incretin physiology and pathophysiology from an Asian perspective
- (2014) Young Min Cho Journal of Diabetes Investigation
- Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
- (2014) Daisuke Yabe et al. Journal of Diabetes Investigation
- Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea
- (2014) Akira Kubota et al. Journal of Diabetes Investigation
- The durability of sitagliptin in elderly patients with type 2 diabetes
- (2014) Ching Jung Hsieh et al. Clinical Interventions in Aging
- Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
- (2013) B. A. Aulinger et al. DIABETES
- Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
- (2013) D. J. Drucker DIABETES
- Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians
- (2013) Jonas B. Møller et al. DIABETES CARE
- Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A systematic review and meta-analysis
- (2013) K. Kodama et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
- (2013) S. Calanna et al. DIABETOLOGIA
- Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
- (2013) Y. G. Kim et al. DIABETOLOGIA
- Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas
- (2013) Yutaka Seino et al. Journal of Diabetes Investigation
- Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study
- (2012) E. S. Hong et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
- (2012) Takafumi Senmaru et al. Journal of Diabetes Investigation
- Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels
- (2012) Masahiro Iwasaki et al. Journal of Diabetes Investigation
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Exendin-4 Suppresses Src Activation and Reactive Oxygen Species Production in Diabetic Goto-Kakizaki Rat Islets in an Epac-Dependent Manner
- (2010) E. Mukai et al. DIABETES
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- GIP and GLP-1, the two incretin hormones: Similarities and differences
- (2010) Yutaka Seino et al. Journal of Diabetes Investigation
- Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
- (2009) K. Aaboe et al. DIABETES OBESITY & METABOLISM
- Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
- (2009) Bo Ahrén et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
- (2009) Adam G Tabák et al. LANCET
- The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs
- (2009) C.-L. Zhang et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started